Genetically modified crops pose a very low risk to human health, and food derived from GM crops are probably as safe as conventional varieties, a scientific study has concluded.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

“On balance, the panel concludes that the risks to human health from GM crops currently on the market are very low,” the report of the government-backed study, published on Monday, was quoted as saying by Reuters.

The report said “there have been no verifiable untoward toxic or nutritionally deleterious effects” on human health, but did not go so far as to claim all GM crops are completely safe.

The scientific panel that carried out the GM Science Review said more research was needed, particularly as new varieties of GM crops enter the market.

“It is clear that gaps in our knowledge and uncertainties will become more complex if the range of plants and traits introduced increases,” the panel said.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The report said concerns that GM crops would cross pollinate with conventional plants to create “superweeds” were largely unfounded. GM crops are “very unlikely to invade our countryside or become problematic plants,” it said.

Just Food Excellence Awards - Nominations Closed

Nominations are now closed for the Just Food Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Winning five categories in the 2025 Just Food Excellence Awards, Centric Software is setting the pace for digital transformation in food and FMCG. Explore how its integrated PLM and PXM suite delivers faster launches, smarter compliance and data-driven growth for complex, multi-channel product portfolios.

Discover the Impact